Gene Therapy Raises Hopes of ED Sufferers

A recent study found a promising new gene therapy that is likely to raise the hopes and more of those suffering erectile dysfunction (ED). This locally administered gene-transfer technology has been validated by data from participants suffering from ED that failed to respond to any known therapy or treatment.

Researchers called this therapy the Maxi-K therapy and observed dramatic changes after Maxi-K therapy, including increases in the number of partial and full erections and a two-fold increase in erection duration. In some men, the effect lasted up to six months. The gene therapy appears safe as no adverse events were reported more than two years after the transfer in some subjects.

Findings of the study are to be presented at the ongoing 103rd Annual scientific meeting of the American Urological Association (AUA).